Dyne Therapeutics (DYN) Earnings Date, Estimates & Call Transcripts → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free dyn Stock Alerts $26.00 +0.17 (+0.66%) (As of 05/2/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 5) -$1.09 Missed By -$0.17 Consensus EPS (Mar. 5) -$0.92 Get Dyne Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DYN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDYN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DYN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Dyne Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.83)($0.83)($0.83)Q2 20241($0.83)($0.83)($0.83)Q3 20241($0.84)($0.84)($0.84)Q4 20241($0.84)($0.84)($0.84)FY 20244($3.34)($3.34)($3.34)DYN Earnings Date and InformationDyne Therapeutics last posted its earnings results on March 5th, 2024. The reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.92) by $0.17. Dyne Therapeutics has generated ($3.94) earnings per share over the last year (($3.94) diluted earnings per share). Earnings for Dyne Therapeutics are expected to grow in the coming year, from ($3.25) to ($3.14) per share. Dyne Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Dyne Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/5/2024Q4 2023($0.92)($1.09)($0.17)($1.09)--10/30/2023Q3 2023($0.83)($0.99)($0.16)($0.99)--8/3/2023Q2 2023($0.81)($1.08)($0.27)($1.08)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)-- Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)-- 5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--$5,000 Gold? (Ad)Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).Find out how to do right here in this free video.3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.64)($0.83)($0.19)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)-- Dyne Therapeutics Earnings - Frequently Asked Questions When is Dyne Therapeutics's earnings date? Dyne Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on DYN's earnings history. Did Dyne Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dyne Therapeutics (NASDAQ:DYN) missed the analysts' consensus estimate of ($0.92) by $0.17 with a reported earnings per share (EPS) of ($1.09). Learn more on analysts' earnings estimate vs. DYN's actual earnings. How much profit does Dyne Therapeutics generate each year? Dyne Therapeutics (NASDAQ:DYN) has a recorded net income of -$235.94 million. DYN has generated -$3.94 earnings per share over the last four quarters. What is Dyne Therapeutics's EPS forecast for next year? Dyne Therapeutics's earnings are expected to grow from ($3.25) per share to ($3.14) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Arvinas Earnings Results Vera Therapeutics Earnings Results Maravai LifeSciences Earnings Results Deciphera Pharmaceuticals Earnings Results Keros Therapeutics Earnings Results Amphastar Pharmaceuticals Earnings Results Rocket Pharmaceuticals Earnings Results Indivior Earnings Results TG Therapeutics Earnings Results Avidity Biosciences Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (NASDAQ:DYN) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.